Nonalcoholic Fatty Liver Disease in Children with Hypopituitarism
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: It has been reported that children with hypopituitarism have features of metabolic syndrome, including obesity, impaired glucose tolerance, and dyslipidemia. The aim of this study was to investigate the clinical features and liver histology of pediatric non-alcoholic fatty liver disease (NAFLD) associated with hypopituitarism. Methods: We reviewed the clinical data of 11 children diagnosed with NAFLD among patients with hypopituitarism. Results: The mean age at the time of diagnosis of hypopituitarism was 10.4±3.2 years, and the mean age at the time of diagnosis of NAFLD was 13.1±2.7 years. A craniopharyngioma was the most common cause of pituitary dysfunction. At the time of diagnosis of NAFLD, 9 patients (82%) had a body mass index greater than the 85th percentile, 5 patients (45%) had elevated fasting blood glucose levels, and 9 patients (82%) had hypertriglyceridemia. The mean height SD score was significantly lower at the time of diagnosis of NAFLD than at the time of diagnosis of hypopituitarism. Of the six patients who were biopsied, one had cirrhosis, two had non-alcoholic steatohepatitis (NASH) with bridging fibrosis, two had NASH with mild portal fibrosis, and one had simple steatosis. Conclusion: Children with hypopituitarism are at risk of short stature, obesity, dyslipidemia, and NAFLD. The early diagnosis of NAFLD is important in children with hypopituitarism because advanced fibrosis is common. (Korean J Pediatr Gastroenterol Nutr 2010; 13: 51∼57)
Abstract
Purpose: It has been reported that children with hypopituitarism have features of metabolic syndrome, including obesity, impaired glucose tolerance, and dyslipidemia. The aim of this study was to investigate the clinical features and liver histology of pediatric non-alcoholic fatty liver disease (NAFLD) associated with hypopituitarism. Methods: We reviewed the clinical data of 11 children diagnosed with NAFLD among patients with hypopituitarism. Results: The mean age at the time of diagnosis of hypopituitarism was 10.4±3.2 years, and the mean age at the time of diagnosis of NAFLD was 13.1±2.7 years. A craniopharyngioma was the most common cause of pituitary dysfunction. At the time of diagnosis of NAFLD, 9 patients (82%) had a body mass index greater than the 85th percentile, 5 patients (45%) had elevated fasting blood glucose levels, and 9 patients (82%) had hypertriglyceridemia. The mean height SD score was significantly lower at the time of diagnosis of NAFLD than at the time of diagnosis of hypopituitarism. Of the six patients who were biopsied, one had cirrhosis, two had non-alcoholic steatohepatitis (NASH) with bridging fibrosis, two had NASH with mild portal fibrosis, and one had simple steatosis. Conclusion: Children with hypopituitarism are at risk of short stature, obesity, dyslipidemia, and NAFLD. The early diagnosis of NAFLD is important in children with hypopituitarism because advanced fibrosis is common. (Korean J Pediatr Gastroenterol Nutr 2010; 13: 51∼57)
참고문헌 (25)
- Patton HM, "Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research", J Pediatr Gastroenterol Nutr, 43, pp.413~427 (2006)
- Hubscher SG, "Histological assessment of non-alcoholic fatty liver disease", Histopathology, 49, pp.450~465 (2006)
- Manco M, "Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis", Int J Obes (Lond), 32, pp.381~387 (2008)
- Srinivasan S, "Features of the metabolic syndrome after childhood craniopharyngioma", J Clin Endocrinol Metab, 89, pp.81~86 (2004)
- Adams LA, "Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction", Hepatology, 39, pp.909~914 (2004)
- 이한효, "뇌하수체저하증과 동반된 원인 미상의 간경변증 1예", 대한내과학회지, 72, pp.116~120 (2007)
- Altuntas B, "Cirrhotic outcome in patients with craniopharyngioma", J Pediatr Endocrinol Metab, 15, pp.1057~1058 (2002)
- Basenau D, "Development of complete liver cirrhosis in hyperphagia-induced fatty liver", Klin Padiatr, 206, pp.62~64 (1994)
- Takano S, "Effect of growth hormone on fatty liver in panhypopituitarism", Arch Dis Child, 76, pp.537~538 (1997)
- Nakajima K, "Pediatric nonalcoholic steatohepatitis associated with hypopituitarism", J Gastroenterol, 40, pp.312~315 (2005)
- 박지용, "청소년기에 간경화증으로 진행된 비알콜성 지방간질환 1예", 대한소아소화기영양학회지, 11(2), pp.204~209 (2008), 대한소아소화기영양학회
- Brunt EM, "Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions", Am J Gastroenterol, 94, pp.2467~2474 (1999)
- Lustig RH, "Risk factors for the development of obesity in children surviving brain tumors", J Clin Endocrinol Metab, 88, pp.611~616 (2003)
- Muller HL, "Obesity after childhood craniopharyngioma-- German multicenter study on pre-operative risk factors and quality of life", Klin Padiatr, 213, pp.244~249 (2001)
- Johansson JO, "Growth hormone-deficient adults are insulin-resistant", Metabolism, 44, pp.1126~1129 (1995)
- Hwu CM, "Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH- deficient adults: a report of one-year clinical experience", J Clin Endocrinol Metab, 82, pp.3285~3292 (1997)
- Kaji H, "Adult growth hormone deficiency in Japan: results of investigation by questionnaire", Endocr J, 49, pp.597~604 (2002)
- Ko JS, "Clinical and histological features of nonalcoholic fatty liver disease in children", Dig Dis Sci, 54, pp.2225~2230 (2009)
- Loria P, "Endocrine and liver interaction: the role of endocrine pathways in NASH", Nat Rev Gastroenterol Hepatol, 6, pp.236~247 (2009)
- Lonardo A, "Growth hormone plasma levels in nonalcoholic fatty liver disease", Am J Gastroenterol, 97, pp.1071~1072 (2002)
- Ichikawa T, "Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency", Gut, 52, pp.914~ (2003)
- Fukuda I, "Metabolic co-morbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature", Endocr J, 55, pp.977~984 (2008)
- Takahashi Y, "Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency", Gastroenterology, 132, pp.938~943 (2007)
- Evans LM, "effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency", Eur J Endocrinol, 142, pp.254~262 (2000)
- Liangpunsakul S, "Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?", J Clin Gastroenterol, 37, pp.340~343 (2003)